Price $44.92 |
Market Cap
75.05B
|
Sector Health Care |
Div. Growth
2.50%
|
|
P/E
14.4
|
P/B
4.87
|
P/S
3.18
|
Dividend %
3.60%
|
|
P/CF
37.3
|
P/FCF
28.5
|
Op. Cash Flow
6.16M
|
FCF
1.5
|
|
Op. Margin
27.80%
|
Net Margin
22.10%
|
ROE
37.30%
|
ROI
25.40%
|
|
ROA
15.10%
|
EPS Growth
462.80%
|
Current Ratio
1.6
|
Debt/Equity
40.20%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Bausch Health Companies Inc (BHC) | $25.00 | - | - | 7.55B | Strong Buy |
| Cocrystal Pharma Inc (COCP) | $2.35 | - | - | 74.4M | Strong Buy |
| China Pharma Holdings, Inc. (CPHI) | $0.29 | - | - | 10.6M | Strong Buy |
| Invo Bioscience Inc (IVOB) | $0.40 | - | - | 56.6M | Strong Buy |
| Champions Oncology Inc (CSBR) | $7.81 | - | - | 110.8M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
